Skip to main content

DA Butterfield

First name:
DA
Last name:
Butterfield
Varadarajan, S. ., Yatin, S. ., Kanski, J. ., Jahanshahi, F. ., & Butterfield, D. . (1999). Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress. Brain Research Bulletin, 50(2), 133-41. https://doi.org/10.1016/s0361-9230(99)00093-3 (Original work published 1999)
Pocernich, C. ., La Fontaine, M. ., & Butterfield, D. . (2000). In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain. Neurochemistry International, 36(3), 185-91. https://doi.org/10.1016/s0197-0186(99)00126-6
Butterfield, D. ., Yatin, S. ., & Link, C. . In vitro and in vivo protein oxidation induced by Alzheimer’s disease amyloid beta-peptide (1-42). Annals of the New York Academy of Sciences, 893, 265-8. https://doi.org/10.1111/j.1749-6632.1999.tb07833.x (Original work published 1999)
Butterfield, D. ., Koppal, T. ., Subramaniam, R. ., & Yatin, S. . Vitamin E as an antioxidant/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurons in culture: insights into Alzheimer’s disease. Reviews in the Neurosciences, 10(2), 141-9. https://doi.org/10.1515/revneuro.1999.10.2.141 (Original work published 1999)
Yatin, S. ., Varadarajan, S. ., Link, C. ., & Butterfield, D. . (1969). In vitro and in vivo oxidative stress associated with Alzheimer’s amyloid beta-peptide (1-42). Neurobiology of Aging, 20(3), 325-30; discussion 339. https://doi.org/10.1016/s0197-4580(99)00056-1 (Original work published 1969)
Lauderback, C. ., Harris-White, M. ., Wang, Y. ., NW, P. . , Jr, Carney, J. ., & Butterfield, D. . Amyloid beta-peptide inhibits Na+-dependent glutamate uptake. Life Sciences, 65(18-19), 1977-81. https://doi.org/10.1016/s0024-3205(99)00459-2 (Original work published 1999)
Butterfield, D. ., Howard, B. ., Yatin, S. ., Koppal, T. ., Drake, J. ., Hensley, K. ., … Carney, J. . Elevated oxidative stress in models of normal brain aging and Alzheimer’s disease. Life Sciences, 65(18-19), 1883-92. https://doi.org/10.1016/s0024-3205(99)00442-7 (Original work published 1999)
Yatin, S. ., Aksenova, M. ., Aksenov, M. ., Markesbery, W. ., Aulick, T. ., & Butterfield, D. . (1998). Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses. Journal of Molecular Neuroscience : MN, 11(3), 183-97. https://doi.org/10.1385/JMN:11:3:183
DeAtley, S. ., Aksenov, M. ., Aksenova, M. ., Jordan, B. ., Carney, J. ., & Butterfield, D. . (1999). Adriamycin-induced changes of creatine kinase activity in vivo and in cardiomyocyte culture. Toxicology, 134(1), 51-62. https://doi.org/10.1016/s0300-483x(99)00039-6 (Original work published 1999)
Aksenov, M. ., Tucker, H. ., Nair, P. ., Aksenova, M. ., Butterfield, D. ., Estus, S. ., & Markesbery, W. . (1999). The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer’s disease. Neurochemical Research, 24(6), 767-74. https://doi.org/10.1023/a:1020783614031